Oral care compositions and methods of use

US11207254B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11207254-B2
Application numberUS-202016777936-A
CountryUS
Kind codeB2
Filing dateJan 31, 2020
Priority dateJun 24, 2016
Publication dateDec 28, 2021
Grant dateDec 28, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are oral care compositions comprising a basic amino acid; a combination of zinc ion sources; and from about 0.75 wt. % to about 2 wt. % of a chelating system; along with methods of making and using same.

First claim

Opening claim text (preview).

We claim: 1. An oral care composition comprising: a. a basic amino acid in free or salt form wherein the amino acid is arginine; b. a combination of zinc ion sources, wherein the zinc ion sources comprise zinc oxide and zinc citrate; and c. from about 0.75 wt. % to about 2 wt. % of a chelating system, wherein the chelating system comprises tetrasodium pyrophosphate; wherein the oral care composition loses less than about 5% of its initial viscosity after 13 weeks. 2. The oral care composition according to claim 1 , comprising from about 1 wt. % to about 2 wt. % of a chelating system. 3. The oral care composition according to claim 1 , comprising about 0.75 wt. %, about 1 wt. %, about 1.25 wt. %, about 1.5 wt. %, about 1.75 wt. %, or about 2 wt. % of a chelating system. 4. The oral care composition according to claim 1 , further comprising a thickening system comprising a polysaccharide gum. 5. The oral care composition according to claim 4 , wherein the polysaccharide gum is xanthan gum and is present in an amount of from about 0.3 wt. % to about 0.8 wt. % of the total weight of the oral care composition. 6. The oral care composition according to claim 4 , wherein the thickening system further comprises from about 5 wt. % to about 10 wt. % silica. 7. The oral care composition according to claim 4 , wherein the thickening system comprises from about 0.5 wt. % to about 15 wt. % of the oral care composition. 8. The oral care composition according to claim 1 , wherein the amino acid is arginine, and is present at about 1.5 wt. %, 5 wt. %, or about 8 wt. %, of the oral care composition. 9. The oral care composition according to claim 1 , wherein the weight ratio of zinc oxide to zinc citrate is about 2:1. 10. The oral care composition according to claim 1 , wherein the zinc citrate is in an amount of about 0.5 wt. % and zinc oxide is present in an amount of about 1.0 wt. % based on the total weight of the oral care composition. 11. The oral care composition according to claim 1 , further comprising a fluoride ion source selected from sodium fluoride, sodium monofluorophosphate, and stannous fluoride. 12. The oral care composition according to claim 11 , wherein the fluoride ion source is present in an amount of from about 0.1 wt. % to 2 wt. % of the total weight of the oral care composition. 13. The oral care composition according to claim 11 , wherein the fluoride ion source provides soluble fluoride in amount of 50 to 25,000 ppm fluoride. 14. The oral care composition according to claim 11 , wherein the fluoride ion source provides soluble fluoride in an amount of about 1450 ppm. 15. The oral care composition according to claim 11 , wherein the fluoride ion source is sodium fluoride, and is present in an amount of about 0.32 wt. %. 16. The oral care composition according to claim 11 , wherein the fluoride ion source comprises stannous fluoride. 17. The oral care composition according to claim 11 , comprising: a. about 1.0 wt. % zinc oxide; b. about 0.5 wt. % zinc citrate; c. about 1.5 wt. % L-arginine; and d. from about 0.75 wt. % to about 2 wt. % of tetrasodium pyrophosphate. 18. The oral care composition according to claim 17 , further comprising from about 0.3 wt. % to about 0.6 wt. % of xanthan gum. 19. The oral care composition according to claim 1 in a form selected from: a toothpaste, a mouthwash, and an oral gel. 20. The oral care composition according to claim 1 , having a G′/G″ ratio of greater than 1 and less than 2. 21. A method to improve oral health comprising applying an effective amount of the oral care composition according to claim 1 to the oral cavity of a subject in need thereof, wherein the method is effective to: i. reduce or inhibit formation of dental caries, ii. reduce, repair or inhibit early enamel lesions, e.g., as detected by quantitative light-induced fluorescence (QLF) or electrical caries measurement (ECM), iii. reduce or inhibit demineralization and promote remineralization of the teeth, iv. reduce hypersensitivity of the teeth, v. reduce or inhibit gingivitis, vi. promote healing of sores or cuts in the mouth, vii. reduce levels of acid producing bacteria, viii. to increase relative levels of arginolytic bacteria, ix. inhibit microbial bio film formation in the oral cavity, x. raise and/or maintain plaque pH at levels of at least pH 5.5 following sugar challenge, xi. reduce plaque accumulation, xii. treat dry mouth, xiii. enhance systemic health, including cardiovascular health, xiv. whiten teeth, xv. reduce erosion of the teeth, xvi. immunize (or protect) the teeth against cariogenic bacteria and their effects, and/or xvii. clean the teeth and oral cavity.

Assignees

Inventors

Classifications

  • A61K8/25Primary

    Silicon; Compounds thereof · CPC title

  • Hydroxycarboxylic acids; Ketocarboxylic acids · CPC title

  • A61K8/44Primary

    Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof · CPC title

  • Thickener, Thickening system · CPC title

  • Polysaccharides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11207254B2 cover?
Described herein are oral care compositions comprising a basic amino acid; a combination of zinc ion sources; and from about 0.75 wt. % to about 2 wt. % of a chelating system; along with methods of making and using same.
Who is the assignee on this patent?
Colgate Palmolive Co
What technology area does this patent fall under?
Primary CPC classification A61K8/25. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).